Ebola Outbreak in the Democratic Republic of Congo Raises Concerns
Health officials in the Democratic Republic of Congo (DRC) are increasingly anxious about an Ebola outbreak in Ituri province. Reports indicate hundreds of suspected cases, with one case already confirmed across the border in Uganda. Notably, this latest strain of the virus lacks a vaccine, as stated by the Africa Centres for Disease Control and Prevention.
The DRC confirmed the outbreak on Friday, as reported by the World Health Organization. Ebola spreads through contact with blood, bodily fluids, or contaminated surfaces. Symptoms can include fever, body aches, weakness, vomiting, and in some instances, bleeding.
Dr. Jean Kaseya, the director general of Africa CDC, mentioned during a video conference on Saturday that officials believe the outbreak began in late April. Currently, there are 336 suspected cases and 87 deaths. Most cases have emerged from two mining towns, Mongwalu and Rwampara, which are frequented by workers. Kaseya referred to the area as “very vulnerable and fragile.”
On May 14, a 59-year-old man from Congo passed away from the virus in Uganda’s capital, Kampala. Dr. Kaseya emphasized the need for protective equipment after outlining the man’s extensive contact with others before his death.
“Someone came from DRC to Uganda and was hospitalized,” he explained. “He took public transportation, so many were exposed.” Tragically, after dying in the hospital, his body was transported back to the DRC for burial, raising concerns about further transmission.
In light of the high transmissibility of the virus, healthcare professionals are advised to use head coverings, goggles, masks, gloves, gowns, and even rubber boots when dealing with Ebola cases.
Kaseya expressed uncertainty about the type of protective gear used by those in contact with the deceased man. “We don’t have local manufacturing for PPE,” he remarked, noting that funding is urgently needed to tackle the issue.
How quickly the virus is spreading remains unclear. Previous outbreaks of this Bundibugyo strain have occurred, but it is less understood compared to the more common Zaire strain of Ebola, and no vaccine currently exists for it. On a promising note, researchers are examining an experimental vaccine that has shown about a 50% efficacy rate in monkeys, though human testing is still pending.
The African CDC has stated it is collaborating with various health organizations and pharmaceutical companies to enhance surveillance, preparedness, and response efforts across borders.
Dr. Craig Spencer, a professor at Brown University who survived a prior Ebola infection, stated on social media that the outbreak is larger than it appears, complicating efforts to track cases and contacts.
Historically, between 2014 and 2016, the largest Ebola outbreak infected over 28,600 people and resulted in 11,325 deaths, starting in Guinea before spreading extensively across West Africa.
